Company Overview and News

9
Singapore's 139-year-old telecom has plans for millennials

2018-07-11 theedgemarkets
SINGAPORE (July 11): Singapore Telecommunications Ltd was around back when the telegraph was still cool. Now the 139-year-old company is experimenting with video games as a way to raise its profile with millennials.
SKM GS.PRB MS.PRE GS.PRA MS.PRF NFLX MS.PRG MS.PRA ATVI GS GLSSP D05 DBSDF SGAPY MS JBK DBSDY SKMD GSC GS.PRICL TFG TPPTY TPM SNGNF GSJ GS.PRJ GS.PRI MS.PRI TPGTF GS.PRD MS.PRK 0700 GS.PRC GJS GS.PRN GS.PRK

8
Singapore’s 139-year-old telecom giant has plans for millennials

2018-07-11 malaymail
SINGAPORE, July 11 — Singapore Telecommunications Ltd (Singtel) was around back when the telegraph was still cool. Now the 139-year-old company is experimenting with video games as a way to raise its profile with millennials.
SKM GS.PRB MS.PRE GS.PRA MS.PRF NFLX MS.PRG MS.PRA ATVI GS GLSSP D05 DBSDF SGAPY MS JBK DBSDY SKMD GSC GS.PRICL TFG TPPTY TPM SNGNF GSJ GS.PRJ GS.PRI MS.PRI TPGTF GS.PRD MS.PRK 0700 GS.PRC GJS GS.PRN GS.PRK

10
Temasek’s big fear is US recession just as trade woes spread

2018-07-11 malaymail
SINGAPORE, July 11 — Temasek Holdings Pte, the Singaporean state investor that signaled its intent to slow its investment pace, fears that slowing economic growth in the US adds to mounting risks just as trade tensions are weighing on global confidence and capital spending.
BABA DBSDY D05 C6L DBSDF SGAPY SINGY SNGNF SINGF

10
Temasek's Big Fear is U.S. Recession Just as Trade Woes Spread - Bloomberg

2018-07-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BABA DBSDY D05 C6L DBSDF SGAPY SINGY SNGNF SINGF

2
Singtel starts Asia gaming tournament in digital content push

2018-07-10 theedgemarkets
SINGAPORE (July 10): Singapore Telecommunications Ltd, Southeast Asia’s largest telecom services provider, will start a regional competitive gaming league as part of its diversification into e-sports and digital content.
GTMEY TPPTY TPM BHRQY GLOPP SNGNF ATVI 532454 GLO TPGTF SGAPY GTMEF BHARTIARTL GLOPA

0
Philippines sheds over 1%; others wary before U.S. tariff deadline

2018-07-05 theedgemarkets
(July 5): Philippine shares fell more than 1% on Thursday, after the country's June inflation hit an over five-year high, while other markets in the region were subdued on caution ahead of Friday's deadline for further U.S. tariffs on Chinese goods.
SMIVY U14 SVTMF UOLGF SGAPY SM UOLGY COL SNGNF

81
Tech start-ups push to make China’s facial recognition systems part of daily life across Asia

2018-07-03 scmp
SenseTime, the world’s most valuable artificial intelligence start-up, joins Megvii and Yitu Technology in establishing a beachhead for Chinese-developed facial recognition applications in major Southeast Asian markets
532454 BABA SGAPY BHRQY BHARTIARTL SNGNF

5
EWS: Singapore Offers Much Better Forward Returns Than The U.S.

2018-07-01 seekingalpha
The United States' market is the only one out of the major markets in the world that looks likely to have negative forward returns.
DBSDY D05 DBSDF SGAPY SNGNF

3
Liberalisation of pay-TV space not seen to impact Astro

2018-06-29 theedgemarkets
Astro Malaysia Holdings Bhd (June 28, RM1.60) Maintain add with an unchanged target price (TP) of RM2.70: The Malaysian Reserve’s interview on Tuesday with the new Communications and Multimedia Minister Gobind Singh Deo centred on the Pakatan Harapan government’s desire to “liberalise” Malaysia’s pay-TV space. With more players entering the field, he said, this would create a healthier market and prompt broadcasters to improve their services.
SGAPY SRHBF 6399 SRHBY SNGNF

0
This is the default headline

2018-06-29 thestar.com.my
THE news that Communications and Multimedia Minister Gobind Singh Deo would like to “liberalise” Malaysia’s pay-TV space is not a surprise to CGSCIMB, nor is it likely to have a significant impact on Astro.
SGAPY SRHBF SRHBY SNGNF

2
TM’s worsening credit outlook boosts consolidation push

2018-06-27 theedgemarkets
Telekom Malaysia Bhd (June 26, RM3.06) We maintain our “buy’ call with an unchanged forecast and fair value of RM4.90/share based on an enterprise value to earnings before interest, taxes, depreciation and amortisation (EV/Ebitda) of five times for the financial year ending Dec 31, 2018 (FY18), which is 0.4 times of Singapore Telecommunications Ltd’s 14 times.
4863 6888 SGAPY AXXTF MYTEF SNGNF

0
Australian PM steps into World Cup streaming row

2018-06-18 theedgemarkets
SYDNEY (June 18): Australia's prime minister intervened on behalf of angry soccer fans on Monday after a series of technical glitches marred viewing of the 2018 World Cup from Russia for a third day.
SGAPY SNGNF

0
Singapore Telecommunications (SGAPY) Investor Presentation - Slideshow

2018-06-14 seekingalpha
The following slide deck was published by Singapore Telecommunications Ltd. ADR in conjunction with this event.
SGAPY SNGNF

94
Retirement: The Future-Proof Portfolio For Young Investors, Bought At A Market High, Is Reducing Its Losses

2018-06-09 seekingalpha
The portfolio was started at the 25th of January, more or less on the market high of 2018.
GLW CHLKF NG ADP INFY SNGNF MDT 0941 CHL ADPVV JNJ SGAPY NGGTF INFY WPC NGG

4
SingTel: Reasonable Valuation, High Dividend

2018-06-08 seekingalpha
Singapore Telecommunications is one of the largest telecommunications providers in the world, with over 700 million customers across Australasia and Africa.
BT.A SGAPY BTGOF ACDSF SNGNF BT

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...